Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy.

MLA

Ribeiro, Isabela Gomes, et al. “Remodeling of Immunological Biomarkers in Patients with Chronic Hepatitis C Treated with Direct-Acting Antiviral Therapy.” Antiviral Research, vol. 190, June 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.antiviral.2021.105073.

APA

Ribeiro, I. G., Coelho-dos-Reis, J. G. A., Fradico, J. R. B., Costa-Rocha, I. A. da, Silva, L. D., Fonseca, L. A. dos S., Stancioli, R. C. S., Teixeira-Carvalho, A., Martins-Filho, O. A., & Teixeira, R. (2021). Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy. Antiviral Research, 190, N.PAG. https://doi.org/10.1016/j.antiviral.2021.105073

Chicago

Ribeiro, Isabela Gomes, Jordana Grazziela Alves Coelho-dos-Reis, Jordana Rodrigues Barbosa Fradico, Ismael Artur da Costa-Rocha, Luciana Diniz Silva, Lucy Ana dos Santos Fonseca, Rhaissa Carvalho Said Stancioli, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, and Rosângela Teixeira. 2021. “Remodeling of Immunological Biomarkers in Patients with Chronic Hepatitis C Treated with Direct-Acting Antiviral Therapy.” Antiviral Research 190 (June): N.PAG. doi:10.1016/j.antiviral.2021.105073.